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View OnlineA LC/UV/Vis method for determination of cyanocobalamin (VB12) in
multivitamin dietary supplements with on-line sample clean-up
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DOI: 10.1039/c0ay00177eA HPLC-UV/Vis method using a two-column strategy with a switching valve for on-line sample clean-
up was developed for the determination of cyanocobalamin (CN–Cbl/Vitamin B12) in multivitamin
dietary supplement tablets. The method uses two columns: an Agilent Zorbax C8 (150 mm 4.6 mm, 5
mm particle size) reversed-phase column and a Waters Symmetry C18 (150 mm 4.6 mm, 5 mm particle
size) reversed-phase column. Chromatographic separation was achieved using a programmed gradient
mobile phase consisting of (A) 0.1% formic acid in water and (B) 0.1% formic acid in acetonitrile.
Because of the low levels of Vitamin B12 in the samples, large injection volumes, and thus much
interfering material, must be used to exceed the limit of quantitation (LOQ) by UV detection. A
switching valve was used to divert most of these early eluting interfering materials to waste, effecting
on-line sample clean-up without excessive sample preparation steps. The recovery of CN–Cbl in the
method was 99.5% and the LOQ was 10 ng per injection. The method was successfully applied to the
analysis of the NIST SRM 3280 multivitamin/multimineral dietary supplement tablet. The method is
specific, precise, and accurate for the intended use. Compared to off-line sample clean-up procedures, it
offers the advantage of being easier, more economical, and less time-consuming.1. Introduction
Vitamin B12 (cobalamin - VB12) is an essential nutrient that can
be found in meat and dairy products or fermented foods (derived
from bacteria). VB12 deficiency affects the growth and repair of
all body cells, namely the hematopoietic cells and the nervous
system cells due to its implication in myelin generation.1 For
adults, the recommended dietary allowance of VB12 is 2.4 mg
day1.2 Because some older people may be unable to absorb
naturally occurring VB12, it has been suggested that those over 50
years of age meet their requirements with VB12 fortified foods or
supplements.2 An additional 0.40 mg day1 is advised for children
and pregnant or lactating women. The average diet generally
contains adequate daily intake of VB12 in a non-vegetarian diet.
2
VB12 is a tetrapyrrole complex which contains cobalt in the
molecule and may refer to several forms of cobalamin. Cyano-
cobalamin (CN–Cbl) and hydroxocobalamin (OH–Cbl) forms of
VB12 are available for medical use. Adenosylcobalamin (Ado–
Cbl), methylcobalamin Me–Cbl), and cobinamide (CN2–Cbn)
are also forms of VB12 found in biological or food samples. In the
United States, CN–Cbl is predominantly used in vitamin prep-
arations, supplements, and medical foods because of its
stability.3,4 Generally VB12 is present in fortified foods or
supplements at levels about 100 to 1000 times lower than other B-
family vitamins such as B1 and B6.
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This journal is ª The Royal Society of Chemistry 2010Today there is increased interest in accurately assessing the
total dietary intake of vitamins from all sources, including foods
and dietary supplements. Demand for rapid, specific, and
updated methodologies for determination of vitamins is growing
because of their importance for health. Several methods such as
chemiluminescence,6 atomic absorption spectrometry (AAS),7
ultraviolet-visible (UV/Vis) spectrometry,8 and voltammetry9,10
have been proposed for the determination of VB12. These
methods do not distinguish cobalamin species and were not
tested in a complex matrix, such as multivitamin or multimineral
dietary supplements. Radioisotope dilution11 and biosensor
based protein-binding assays12,13 have also been described.
However, cobalamin analogues react with the binding protein
used in the assays leading to lack of specificity for these
methods.14,15
Currently, microbiological assays (MBA) from the AOAC
INTERNATIONAL, which use Lactobacillus leishmannii as
a test organism, are utilized for the routine determination of
VB12 in foodstuffs.
16,17 These non-specific MBA are not capable
of distinguishing between the cobalamin analogues because they
rely on the conversion of all cobalamins to CN–Cbl using KCN.
MBA may also be influenced by other food components such as
deoxyribosides and deoxynucleotides.18 Although they have high
sensitivity, MBA are time-consuming and present high vari-
ability, requiring multiple determinations to get good estimates.15
Several studies have determined all cobalamin species together
and report total cobalamin,5,19,20 but many perform selective
determination of cobalamin species. The most widely used
chemical methods for VB12 determination are capillary electro-
phoresis21,22 and high-performance liquid chromatography
(HPLC) with various detection methods such as UV/VIS,23–28
AAS,29 fluorescence,14,30 or mass spectrometric detectors.20,23,31–34Anal. Methods, 2010, 2, 1171–1175 | 1171
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View OnlineTo determine VB12 in a complex matrix, usually an off-line clean-
up step, such as solid-phase extraction (SPE), was needed.15,19,25
Since the main form of cobalamin used in dietary supplements
and fortified foods in the USA is CN–Cbl, this form was used in
this study. The study focused on the development of an easy,
economical, fast, and accurate method for VB12 quantitation in
multivitamin dietary supplement tablets without an off-line
sample clean-up procedure, thus the UV/Vis detector was
selected as the detector of choice.
2. Experimental
2.1. Reagents and materials
Water, acetonitrile and methanol were Optima* grade (Fisher
Scientific, Pittsburgh, PA) while formic acid is mass spectrometry
grade (Sigma/Aldrich, St. Louis, MO). Cyanocobalamin (CN–
Cbl) (CAS 68-19-9; MW 1,355.37) was obtained from Sigma-
Aldrich (St. Louis, MO, USA) and was stored in a refrigerator
(5 C) as required to ensure stability. Stock solutions were
prepared under low-light conditions and stored in the refriger-
ator (5 C). Standard reference material (SRM) multivitamin/
multimineral dietary supplement tablets (SRM 3280) were
obtained from the National Institute of Standards and Tech-
nology (NIST, Gaithersburg, MD). Use of a SRM provides
a stable and homogeneous test material with known B12 values to
test and validate the method. Open availability of the SRM will
make it suitable for use by other laboratories to test proper
implementation of this method. Five different vitamins samples
from major vitamin supplement manufactures were purchased
via internet retailers, the samples included 3 tablets, 1 chewable
tablet, and 1 liquid.
2.2. Apparatus
An Agilent 1100 HPLC system (Agilent Technologies, Palo Alto,
CA) was used, consisting of a quaternary pump with a vacuum
degasser, a thermostatted column compartment, an auto-
sampler, and a diode array detector (DAD).
Two analytical columns were used. Column 1 was an Agilent
Zorbax C8 reversed-phase column (150 mm  4.6 mm, 5 mm
particle size, Agilent Technologies, Palo Alto, CA) and column 2
was a Waters Symmetry C18 reversed-phase column (150 mm 
4.6 mm, 5 mm particle size, Waters, Milford, MA, USA).
A mortar grinder Retsch Rm-100 (Retsch GmbH & Co. KG,
Germany) and a IEC Clinical Centrifuge (Danon/IEC Division
Needham H.T.S., USA) were also used.
2.3. Sample preparation
A composite of 20 tablets of solid-form vitamin supplements
(including SRM 3280) was accurately weighed and ground to
a uniform powder with the mortar grinder for 15 min. Approx-
imately the weight of a single tablet of each sample (the average
weight of one tablet) was weighed and transferred into a red-
color 10 mL volumetric flask. 10 mL H2O was added and the
flask was sonicated in the dark for 30 min. The content was then
decanted into a 15 mL centrifuge tube and was centrifuged for 15
min at 5,000 g. The supernatant was filtered through a 0.45 mm
PVDF filter. Samples were prepared under low-light conditions1172 | Anal. Methods, 2010, 2, 1171–1175throughout and stored in the dark at 5 C before use. The liquid
sample was diluted with H2O to the appropriate concentration
according to the label claim.
2.4. Two-column chromatography/DAD conditions
Chromatographic separation was achieved using a programmed
gradient mobile phase consisting of (A) 0.1% formic acid in water
and (B) 0.1% formic acid in acetonitrile. The gradient is as
follows: 0–12 min, linear gradient from 95 : 5 A:B (v/v) to 75 : 25
A:B (v/v); 12–15 min, linear gradient from 75 : 25 A:B (v/v) to
5 : 95 A:B (v/v); 15–17 min, isocratic at 5 : 95 A:B (v/v); 17–17.1
min, back to 97 : 5 A:B (v/v); 17.1–25 min, isocratic at 95 : 5 A:B
(v/v, column equilibrating). The flow rate used was 1 mL min1
and the injection volumes were 100 mL. The HPLC analysis was
carried out using two columns connected in series with
a switching valve sandwiched in between (Agilent Zorbax
column to switching valve to Waters Symmetry column). For the
first 8 min of the HPLC run, the eluent was diverted to a waste
line; at 8 min, the eluent was switched from the waste to the
Waters Symmetry column. UV/Vis detection was carried out at
550 nm.
3. Results and discussion
3.1. Sample preparation
Because CN–Cbl is a water-soluble vitamin and stable when
protected from light, H2O is a good extraction solvent. Water, 10
mM KCl solution, 10 mM phosphate buffers at pH 2.5 and at pH
4.3 were investigated for the extraction of CN–Cbl and no
significant differences in quantitation were observed in the
results.
3.2. Chromatography
Since the CN–Cbl content in a single tablet was estimated to be
approximately 10 mg, it was necessary to inject the maximum
possible amount of sample in order to exceed the limit of
quantitation (LOQ) of the diode array detector (DAD). The
amount of sample injected per analysis in this study (10 mL
extraction solvent per tablet with 100 mL injection) was about
2000 times greater compared to our previous studies on the
analysis of other B-vitamins in SRM 3280 (1000 mL extraction
solvent per tablet with 5 mL injection).35 For HPLC analysis of
CN–Cbl in this amount of extracted material, usually a clean-up
step, such as off-line solid phase extraction (SPE), is commonly
used.5,15,19,25 Off-line sample clean-up methods are usually
expensive, laborious, and time consuming. One of the goals of
this study was to not use any off-line sample clean-up procedure
except a simple filtration. Initially, an on-line SPE method
(Waters Oasis HLB on-line SPE column, 20 mm  3.9 mm, 20
mm particle size, Waters, Milford, MA, USA) was investigated.
The result was not satisfactory, due to the fact that the amount of
material (other vitamins and minerals) injected exceeded the
loading capacity of the column. A bigger column, such as
a regular 4.6 mm HPLC column, was better suited to handle the
task. Thus, a two-column strategy was investigated. The 1st
column did not have to have the loading capacity to hold all of
the material injected as long as it retained all of the CN–Cbl. AThis journal is ª The Royal Society of Chemistry 2010
Fig. 1 HPLC-UV/Vis chromatograms of CN–Cbl standard and SRM 3280 extract (UV l ¼ 550 nm).
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View Onlinevariety of reversed-phase HPLC columns from different manu-
facturers were tested as the 1st column. After screening a series of
C18 and C8 columns, the Agilent Zorbax C8 column was found
to be the best. Then, 2nd stage columns were screened and the
Waters Symmetry C18 column was found to give the best peak
shape and separation for CN–Cbl when combined with the
Agilent Zorbax C8 column. The HPLC gradient and the time of
the switching were optimized based on the combination of the
two columns. The conditions selected in the developed method
(see Experimental section) gave excellent separation within 25
min with a sharp and symmetric CN–Cbl peak (Fig. 1).Fig. 2 UV/Vis spectrum of the CN–Cbl standard and SRM 3280
This journal is ª The Royal Society of Chemistry 20103.3. Sample analysis
The chromatogram at 550 nm showed that the CN–Cbl peak at
10.4 min was well separated from the vitamin B2 (riboflavin)
peak at 11.4 min in the NIST SRM 3280 multivitamin dietary
supplement (Fig. 1). The identities of the CN–Cbl peaks (m/z
1356.4, 10.4 min) in both CN–Cbl standard and the NIST SRM
3280 and the B2 peak (m/z 377.3, 11.4 min) in the NIST SRM
3280 were confirmed by mass spectrometry (Waters Quattro
Micro triple-quad mass spectrometer, Waters, Milford, MA).
The UV/Vis spectra from both CN–Cbl and the SRM 3280 showextract from the HPLC chromatogram (UV/Vis 300–700 nm).
Anal. Methods, 2010, 2, 1171–1175 | 1173
Table 3 Analysis of commercial multi-vitamin dietary supplements a,b
Samples Sample 1 Sample 2 Sample 3 b Sample 4 Sample 5
Measured
amount
74.48 
0.16
144.10 
0.62
0.27 
0.01
3.30 
0.03
4.40 
0.07
Labeled
amount
57.10 122.67 0.30 2.68 3.34
a Expressed as mass fraction (mg g1) for all samples except for sample 3
(liquid form, mg mL1). b n ¼ 3.
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View Onlinethe most distinctive peaks at 362 and 550 nm (Fig. 2). However,
there is considerably more absorbance between UV 300–UV 340
nm from the matrix of NIST SRM 3280. At above 450 nm, there
are no significant matrix effects on the spectrum of CN–Cbl. So
550 nm was selected as the wavelength for CN–Cbl quantitation.
The LC/UV/Vis method described was tested with respect to
sensitivity [the limit of detection (LOD) and the limit of quan-
tification (LOQ)], linearity, intra-day precision (n ¼ 6) at three
different concentrations, intermediate precision (n ¼ 3) for five
consecutive days, and accuracy.
3.3.1. LOD, LOQ, range, and linearity. The limit of detection
(LOD) is 3.3 ng/inj and the limit of quantification (LOQ) is 10.0
ng/inj. The LOD and LOQ were calculated based on signal to
noise ratios of 3 and 10 (S/N¼ 3 and 10), respectively. Compared
with previously reported HPLC methods using UV/Vis detec-
tion, the obtained LOD with the present method (3.3 ng mL1)
was more sensitive than methods optimized by Moreno et al.19 (4
ng/inj), Klejdus et al.25 (9.7 ng/inj) and Wongyai et al.5 (100 ng/
inj), and similar to the one reported by Heudi et al.15 (3 ng/inj).
The working range of 10–1000 ng mL1 is estimated from the
LOQ (10 ng mL1) up to 1000% of the estimated concentration of
the CN–Cbl level existing in the extract. Excellent linearity was
observed for the calibration plot of peak area versus concentra-
tion (y ¼ 0.3622x  2.3987, R2 ¼ 0.9998).
3.3.2. Intra-day and inter-day precisions. The intra-day
precision of the chromatographic system was evaluated by
injection of CN–Cbl standards at three different concentration
levels (n ¼ 6, Table 1). The intermediate precision of the method
performance was tested for 5 days (n ¼ 3 except the 1st day, n ¼
6, Table 2). The overall relative standard deviation (RSD) for the
5 days’ results was 0.84%.
3.3.3. Accuracy. Averaging of all 5 days’ results from the
intermediate precision study (Table 2), the amount of the CN–Table 1 Intra-day precision of the LC/UV methoda,b
Concentration/mg g1 SD (n ¼ 6) RSD%
3.02 0.04 1.42
6.00 0.02 0.30
10.56 0.12 1.17
a Within-day precision, UV 550 nm. Expressed as mass fraction (mg g1)
of the NIST SRM 3280. b In order to better judge the intra-day precision
of the method, one diluted, one normal, and one spiked SRM 3280
sample were used in the experiment.
Table 2 Intermediate precision of the LC/UV methoda,b
Day 1 Day 2 Day 3 Day 4 Day 5
Overall
RSD (%)
6.04 
0.04
6.07 
0.06
6.01 
0.02
5.99 
0.01
6.00 
0.02
0.84%
a Inter-day precision, UV 550 nm. Expressed as mass fraction (mg g1) of
the NIST SRM 3280. b n ¼ 6 (Day 1) and n ¼ 3 (Day 2–5).
1174 | Anal. Methods, 2010, 2, 1171–1175Cbl contained in SRM 3280 is 6.02 0.05 mg g1 (mass fraction).
Our values are accurate within the certified value and uncer-
tainties in the Certificate of Analysis for NIST SRM 3280 of 4.9
 1.9 mg g1 (mass fraction).36
3.3.4. Recovery and matrix effects. For recovery studies,
known amounts of CN–Cbl (equivalent to 50%, 100%, and 200%
of expected vitamin concentration of the analyzed sample) were
added to the respective aliquots of the tablet powder prior to
sample preparation. The recovery of added CN–Cbl calculated
was 99.5  2.8%, the recovery from the certificate analysis was
122.8%  31.6%.
Since it was impossible to obtain the blank matrix for the
SRM 3280 used, the standard addition method was used to
evaluate matrix interference37 in the detection system.
Different amounts of CN–Cbl standards were added to
a sample extract at approximately 50%, 100%, 150%, and
200% of the estimated CN–Cbl level. Expressed as relative
error, the magnitude of matrix effects can be calculated by the
following equation:
Relative Error (%) ¼ (100  |X  A|)/A
Where X¼mean value obtained through the standard curve and
A ¼ mean value obtained through the standard addition curve.
The relative error due to matrix effects calculated for the LC/
UV/Vis method is 0.35%, showing matrix effects to be non-
significant.
3.3.5 Analysis of commercial samples. The results of the
amount of CN–Cbl contained in each of the commercial samples
are listed in Table 3. Generally the measured amounts of the CN–
Cbl are higher than the label claims. This is not surprising since it
is well-known that manufacturers often deliberately add more
vitamins than the label claims in order to have extended shelf-life.
The lone exception among the commercial samples is the liquid
form vitamin supplements, the measured amount is about 10%
lower compared to the label claim. The reason might be that CN–
Cbl in liquid is not as stable as in a tablet and degradation might
have occurred.
4. Conclusion
This study provided an improved approach for the analysis of
CN–Cbl, which normally exists at low concentration in multi-
vitamin dietary supplements. The method does not use any off-
line sample clean-up/concentration procedures that are expensive
and laborious. The proposed 2-column HPLC-UV/Vis method isThis journal is ª The Royal Society of Chemistry 2010
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View Onlinesensitive and reproducible with good precision and accuracy.
This method is easy, economical, and efficient. Consequently,
this analytical method can be considered as a valid alternative to
those that require an off-line sample clean-up procedure or
require a mass spectrometer for analysis of VB12 in dietary
supplements.
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